Maternal depression or anxiety during pregnancy and offspring type 1 diabetes : a population-based family-design cohort study
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ..
INTRODUCTION: To investigate the association between maternal depression/anxiety during pregnancy and offspring type 1 diabetes, to assess the specific importance of exposure during pregnancy by comparing across different exposure periods before and/or after pregnancy, and to explore potential unmeasured familial confounding.
RESEARCH DESIGN AND METHODS: This was a population-based cohort including 1 807 809 offspring born in Sweden 2002-2019. From national registers, data were available on diagnosis or medication prescription for depression/anxiety in and around pregnancy, as well as incident cases of type 1 diabetes defined through diagnosis or insulin treatment. Associations were examined using flexible parametric and Cox regression models. Familial confounding was explored using paternal exposure as a negative control and by comparing offspring exposed to maternal depression/anxiety with their unexposed siblings.
RESULTS: For exposure during pregnancy, maternal depression/anxiety was associated with an increased risk of offspring type 1 diabetes onset after, but not before, 8 years of age (adjusted HR (aHR) 1.21 (95% CI 1.03 to 1.42]). Exposure occurring only during pregnancy was similarly associated to type 1 diabetes (aHR 1.24 (0.96 to 1.60)), whereas exposure occurring only before pregnancy was not (aHR 0.91 (0.64 to 1.30)). Associations were close to the null for paternal depression/anxiety (aHR 0.95 (0.72 to 1.25)), and point estimates were above 1 in sibling comparisons, although with wide CIs (aHR 1.36 (0.82 to 2.26)).
CONCLUSIONS: Maternal depression/anxiety specifically during pregnancy seems to be associated with offspring type 1 diabetes. Paternal negative control and sibling comparisons indicate that the results cannot entirely be explained by familial confounding.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
BMJ open diabetes research & care - 11(2023), 2 vom: 20. Apr. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Smew, Awad I [VerfasserIn] |
---|
Links: |
---|
Themen: |
Diabetes mellitus, type 1 |
---|
Anmerkungen: |
Date Completed 24.04.2023 Date Revised 12.05.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1136/bmjdrc-2023-003303 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM35584382X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM35584382X | ||
003 | DE-627 | ||
005 | 20231226065215.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/bmjdrc-2023-003303 |2 doi | |
028 | 5 | 2 | |a pubmed24n1186.xml |
035 | |a (DE-627)NLM35584382X | ||
035 | |a (NLM)37080595 | ||
035 | |a (PII)e003303 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Smew, Awad I |e verfasserin |4 aut | |
245 | 1 | 0 | |a Maternal depression or anxiety during pregnancy and offspring type 1 diabetes |b a population-based family-design cohort study |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.04.2023 | ||
500 | |a Date Revised 12.05.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. | ||
520 | |a INTRODUCTION: To investigate the association between maternal depression/anxiety during pregnancy and offspring type 1 diabetes, to assess the specific importance of exposure during pregnancy by comparing across different exposure periods before and/or after pregnancy, and to explore potential unmeasured familial confounding | ||
520 | |a RESEARCH DESIGN AND METHODS: This was a population-based cohort including 1 807 809 offspring born in Sweden 2002-2019. From national registers, data were available on diagnosis or medication prescription for depression/anxiety in and around pregnancy, as well as incident cases of type 1 diabetes defined through diagnosis or insulin treatment. Associations were examined using flexible parametric and Cox regression models. Familial confounding was explored using paternal exposure as a negative control and by comparing offspring exposed to maternal depression/anxiety with their unexposed siblings | ||
520 | |a RESULTS: For exposure during pregnancy, maternal depression/anxiety was associated with an increased risk of offspring type 1 diabetes onset after, but not before, 8 years of age (adjusted HR (aHR) 1.21 (95% CI 1.03 to 1.42]). Exposure occurring only during pregnancy was similarly associated to type 1 diabetes (aHR 1.24 (0.96 to 1.60)), whereas exposure occurring only before pregnancy was not (aHR 0.91 (0.64 to 1.30)). Associations were close to the null for paternal depression/anxiety (aHR 0.95 (0.72 to 1.25)), and point estimates were above 1 in sibling comparisons, although with wide CIs (aHR 1.36 (0.82 to 2.26)) | ||
520 | |a CONCLUSIONS: Maternal depression/anxiety specifically during pregnancy seems to be associated with offspring type 1 diabetes. Paternal negative control and sibling comparisons indicate that the results cannot entirely be explained by familial confounding | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a diabetes mellitus, type 1 | |
650 | 4 | |a epidemiology | |
650 | 4 | |a pregnancy | |
650 | 4 | |a stress, psychological | |
700 | 1 | |a Lundholm, Cecilia |e verfasserin |4 aut | |
700 | 1 | |a Gong, Tong |e verfasserin |4 aut | |
700 | 1 | |a Sävendahl, Lars |e verfasserin |4 aut | |
700 | 1 | |a Lichtenstein, Paul |e verfasserin |4 aut | |
700 | 1 | |a Brew, Bronwyn K |e verfasserin |4 aut | |
700 | 1 | |a Almqvist, Catarina |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMJ open diabetes research & care |d 2013 |g 11(2023), 2 vom: 20. Apr. |w (DE-627)NLM244073775 |x 2052-4897 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2023 |g number:2 |g day:20 |g month:04 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjdrc-2023-003303 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2023 |e 2 |b 20 |c 04 |